Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |
DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Reach Grants |
2016 |
Pennsylvania |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine / Michael Engel, MD/PhD |
Reach Grants |
2016 |
Virginia |
Targeting PLK1 as a Common Mechanism in Ph-like ALL |
University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD |
Reach Grants |
2016 |
Texas |
Enhancing Pediatric Sarcoma Immunotherapy by Drug Induced Expression of Tumor-Specific Cryptic Neoantigens |
University of Minnesota / David Largaespada, PhD |
Innovation Grants |
2016 |
Minnesota |
Image Guided Diffuse Intrinsic Pontine Glioma Drug Delivery and Design |
Weill Cornell Medical College / Mark Souweidane, MD & Richard Ting, PhD |
Innovation Grants |
2016 |
New York |
Redefining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-seq Analyses |
Massachusetts General Hospital / Mario Suva, MD/PhD |
Innovation Grants |
2016 |
Massachusetts |
Circulating Exosomes as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence |
Weill Cornell Medical College / David Lyden, MD/PhD & Parveen Raju, MD/PhD |
Innovation Grants |
2016 |
New York |
Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC) |
University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD |
Epidemiology Grants |
2016 |
California |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |